Pittenger & Anderson Inc’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-632
| Closed | -$43.7K | – | 432 |
|
|
2023
Q2 | $43.7K | Sell |
632
-3,950
| -86% | -$281K | ﹤0.01% | 282 |
|
|
2023
Q1 | $340K | Sell |
4,582
-1,170
| -20% | -$98.1K | 0.02% | 175 |
|
|
2022
Q4 | $536K | Buy |
5,752
+860
| +18% | +$83K | 0.03% | 157 |
|
|
2022
Q3 | $467K | Sell |
4,892
-250
| -5% | -$24.7K | 0.03% | 157 |
|
|
2022
Q2 | $476K | Hold |
5,142
| – | – | 0.03% | 161 |
|
|
2022
Q1 | $520K | Buy |
5,142
+715
| +16% | +$75.1K | 0.03% | 161 |
|
|
2021
Q4 | $457K | Hold |
4,427
| – | – | 0.02% | 171 |
|
|
2021
Q3 | $376K | Buy |
4,427
+1,000
| +29% | +$83.8K | 0.02% | 174 |
|
|
2021
Q2 | $286K | Buy |
3,427
+1,300
| +61% | +$106K | 0.01% | 180 |
|
|
2021
Q1 | $160K | Buy |
2,127
+75
| +4% | +$5.46K | 0.01% | 213 |
|
|
2020
Q4 | $140K | Sell |
2,052
-51,175
| -96% | -$3.33M | 0.01% | 216 |
|
|
2020
Q3 | $3.11M | Buy |
53,227
+6,725
| +14% | +$418K | 0.2% | 109 |
|
|
2020
Q2 | $3.02M | Buy |
46,502
+40,650
| +695% | +$2.56M | 0.21% | 103 |
|
|
2020
Q1 | $347K | Hold |
5,852
| – | – | 0.03% | 176 |
|
|
2019
Q4 | $435K | Buy |
5,852
+250
| +4% | +$17.6K | 0.03% | 192 |
|
|
2019
Q3 | $353K | Buy |
5,602
+2,300
| +70% | +$136K | 0.03% | 197 |
|
|
2019
Q2 | $180K | Buy |
3,302
+3,113
| +1,647% | +$168K | 0.01% | 213 |
|
|
2019
Q1 | $10K | Sell |
189
-925
| -83% | -$57.1K | ﹤0.01% | 328 |
|
|
2018
Q4 | $73K | Buy |
1,114
+1,012
| +992% | +$75.5K | 0.01% | 241 |
|
|
2018
Q3 | $8K | Buy |
102
+26
| +34% | +$1.86K | ﹤0.01% | 332 |
|
|
2018
Q2 | $5K | Sell |
76
-600
| -89% | -$39.5K | ﹤0.01% | 352 |
|
|
2018
Q1 | $42K | Sell |
676
-11,144
| -94% | -$800K | ﹤0.01% | 275 |
|
|
2017
Q4 | $857K | Buy |
11,820
+35
| +0.3% | +$2.54K | 0.08% | 181 |
|
|
2017
Q3 | $958K | Sell |
11,785
-32,935
| -74% | -$2.61M | 0.09% | 168 |
|
|
2017
Q2 | $3.6M | Sell |
44,720
-1,150
| -3% | -$90.8K | 0.34% | 76 |
|
|
2017
Q1 | $3.6M | Buy |
45,870
+855
| +2% | +$68.3K | 0.36% | 76 |
|
|
2016
Q4 | $3.55M | Sell |
45,015
-18,330
| -29% | -$1.48M | 0.38% | 71 |
|
|
2016
Q3 | $5.64M | Buy |
63,345
+1,490
| +2% | +$141K | 0.63% | 37 |
|
|
2016
Q2 | $5.92M | Buy |
61,855
+5,150
| +9% | +$513K | 0.65% | 32 |
|
|
2016
Q1 | $5.88M | Buy |
56,705
+4,345
| +8% | +$422K | 0.68% | 25 |
|
|
2015
Q4 | $5.12M | Buy |
52,360
+5,015
| +11% | +$491K | 0.64% | 30 |
|
|
2015
Q3 | $4.57M | Buy |
47,345
+1,305
| +3% | +$137K | 0.6% | 30 |
|
|
2015
Q2 | $4.83M | Buy |
46,040
+585
| +1% | +$59.8K | 0.62% | 27 |
|
|
2015
Q1 | $4.69M | Buy |
45,455
+895
| +2% | +$90.6K | 0.6% | 33 |
|
|
2014
Q4 | $4.29M | Buy |
44,560
+2,155
| +5% | +$190K | 0.57% | 37 |
|
|
2014
Q3 | $3.38M | Buy |
42,405
+1,170
| +3% | +$92.2K | 0.49% | 44 |
|
|
2014
Q2 | $3.11M | Sell |
41,235
-4,875
| -11% | -$368K | 0.46% | 51 |
|
|
2014
Q1 | $3.45M | Sell |
46,110
-150
| -0.3% | -$10.6K | 0.48% | 38 |
|
|
2013
Q4 | $3.31M | Buy |
46,260
+1,100
| +2% | +$70.7K | 0.46% | 40 |
|
|
2013
Q3 | $2.56M | Sell |
45,160
-325
| -0.7% | -$19.4K | 0.41% | 55 |
|
|
2013
Q2 | $2.6M | Buy |
+45,485
| New | +$2.64M | 0.45% | 52 |
|
Other funds holding CVS
Pittenger & Anderson Inc's CVS Position: Q3 2023 in Review
Pittenger & Anderson Inc sold out of CVS Health (CVS) in Q3 2023, closing a stake of 632 shares — an estimated $43.7K sold.
Pittenger & Anderson Inc first reported a position in CVS in Q2 2013 and held it in 41 quarters. The position peaked at $5.92M in Q2 2016. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.
- Pittenger & Anderson Inc reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
- Pittenger & Anderson Inc sold 632 CVS Health shares in Q3 2023, an estimated $43.7K.
- Pittenger & Anderson Inc first reported a position in CVS Health in Q2 2013 and held it in 41 quarters.
- Pittenger & Anderson Inc's CVS Health position peaked at $5.92M in Q2 2016.
- 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.
Based on Pittenger & Anderson Inc's 13F filing for Q3 2023, filed 2 Nov 2023.